Central Trust Company’s Soleno Therapeutics SLNO Stock Holding History

Central Trust Company’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2	Closed	-$67	–	1669
2026 Q1	$67	Hold	2	–	–	﹤0.01%	1560
2025 Q4	$93	Buy	+2	New	+$110	﹤0.01%	1534

Central Trust Company's SLNO Position: Q2 2026 in Review

Central Trust Company sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 2 shares — an estimated $67 sold.

Central Trust Company first reported a position in SLNO in Q4 2025 and held it in 2 quarters. The position peaked at $93 in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Central Trust Company reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Central Trust Company sold 2 Soleno Therapeutics shares in Q2 2026, an estimated $67.
Central Trust Company first reported a position in Soleno Therapeutics in Q4 2025 and held it in 2 quarters.
Central Trust Company's Soleno Therapeutics position peaked at $93 in Q4 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.